Gene Therapy For CNS Disorders Report

By www.reliableresearchiq.com

Report Details

Report Name

Global And United States Gene Therapy For CNS Disorders Market Report & Forecast 2023-2028 Story

Pages

93

Price

$ 4350

Features

Gene Therapy For CNS Disorders Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Gilead (Kite Pharma)
Amgen (BioVex)
Novartis
Roche (Spark Therapeutics)
Bluebird Bio